Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer
LEXINGTON, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven […]
Auxly Strengthens its Board and Announces Additional Steps on Path to Profitability
Auxly Founder & Chair Chuck Rifici has resigned from the Board of Directors; independent director Genevieve Young appointed new Chair, […]
Maura Lendon Nominated to Revival Gold Board
TORONTO, Oct. 01, 2020 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQB: RVLGF) (“Revival Gold” or the “Company”), a […]
Constellation Brands Reports Second Quarter Fiscal 2021 Results
VICTOR, N.Y., Oct. 01, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, […]
NexTech’s InfernoAR Video Conferencing Platform Expanding Sales To USA and International Government Contracts
VANCOUVER, British Columbia, Oct. 01, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an […]
Fulcrum Therapeutics Announces Multiple Presentations During the Virtual 25th International Congress of the World Muscle Society
CAMBRIDGE, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]
Cara Therapeutics Appoints Thomas Reilly as Chief Financial Officer
STAMFORD, Conn., Oct. 01, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing […]
Akouos Announces Key Leadership Appointments
BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential […]
VYNE Therapeutics Announces ZILXI™ (minocycline) topical foam, 1.5% is Available in Pharmacies Nationwide Today, October 1st
ZILXI is the First FDA Approved Minocycline Product for the Treatment of Inflammatory Lesions of Rosacea in AdultsZILXI Offers Efficacy […]
ReSPECT Glioblastoma Clinical Trial Data to be Presented at 2020 Society for Neuro-Oncology Annual Meeting
AUSTIN, Texas, Oct. 01, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that its abstract regarding […]
